Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
428.26
-0.17 (-0.04%)
At close: Oct 16, 2026, 4:00 PM EDT
428.25
-0.01 (0.00%)
After-hours: Oct 16, 2026, 4:59 PM EDT
Elevance Health Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 50,474 | 50,181 | 49,748 | 50,711 | 49,776 | 48,891 | 45,442 | 45,145 | 43,646 | 42,577 | 42,647 | 42,849 | 43,672 | 42,172 | 39,933 | 39,939 | 38,632 | 38,095 | 36,585 | 35,822 |
Revenue Growth | 1.40% | 2.64% | 9.48% | 12.33% | 14.04% | 14.83% | 6.55% | 5.36% | -0.06% | 0.96% | 6.80% | 7.29% | 13.05% | 10.70% | 9.15% | 11.49% | 14.12% | 17.63% | 14.96% | 14.97% |
Operating Income Operating Income Growth | 2,301 | 2,661 | 766 | 1,757 | 2,633 | 3,141 | 1,255 | 2,378 | 3,026 | 3,204 | 2,404 | 1,913 | 2,702 | 2,870 | 1,317 | 2,340 | 2,330 | 2,507 | 1,829 | 2,197 |
Net Income Net Income Growth | 1,463 | 1,764 | 547 | 1,189 | 1,743 | 2,183 | 418 | 1,016 | 2,300 | 2,246 | 856 | 1,289 | 1,853 | 1,989 | 865 | 1,603 | 1,637 | 1,789 | 1,137 | 1,509 |
Earnings Per Share EPS Growth | 6.71 | 8.00 | 2.47 | 5.32 | 7.72 | 9.61 | 1.81 | 4.36 | 9.85 | 9.59 | 3.63 | 5.45 | 7.79 | 8.30 | 3.59 | 6.62 | 6.73 | 7.32 | 4.63 | 6.13 |
EPS Growth | -13.08% | -16.75% | 36.35% | 22.02% | -21.62% | 0.21% | -50.17% | -20.00% | 26.44% | 15.54% | 1.22% | -17.67% | 15.75% | 13.39% | -22.57% | 7.99% | -7.17% | 9.09% | 111.06% | 604.60% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Health Benefits Health Benefits Growth | 42,720 | 42,490 | 41,835 | 42,246 | 41,582 | 41,431 | 37,580 | 38,278 | 37,159 | 37,258 | 36,547 | 36,744 | 38,000 | 37,280 | 34,996 | 35,065 | 34,396 | 34,027 | 31,817 | 31,521 |
CarelonRx CarelonRx Growth | 11,250 | 10,600 | 11,644 | 10,997 | 10,643 | 10,116 | 9,977 | 9,143 | 8,774 | 8,067 | - | - | - | - | - | - | - | - | - | - |
Carelon Services Carelon Services Growth | 7,975 | 7,365 | 7,015 | 7,324 | 7,441 | 6,536 | 4,769 | 4,638 | 4,545 | 4,009 | - | - | - | - | - | - | - | - | - | - |
Corporate & Other Corporate & Other Growth | 6 | 4 | -83 | 149 | 232 | 165 | -14 | 74 | 122 | 127 | 181 | 95 | 112 | 91 | 58 | 211 | 315 | 273 | - | - |
Revenue (Total) Revenue (Total) Growth | 49,826 | 49,494 | 49,311 | 50,087 | 49,421 | 48,765 | 44,989 | 44,719 | 43,223 | 42,273 | 42,454 | 42,480 | 43,377 | 41,898 | 39,667 | 39,625 | 38,482 | 37,886 | 36,018 | 35,548 |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 10,232 | 9,657 | 9,491 | 8,713 | 8,560 | 7,500 | 8,288 | 7,866 | 6,497 | 6,226 | 6,526 | 10,919 | 9,991 | 10,142 | 7,387 | 8,872 | 6,456 | 6,161 | 4,880 | 5,490 |
Total Debt Total Debt Growth | 31,044 | 31,842 | 32,750 | 32,102 | 30,186 | 30,003 | 32,193 | 27,148 | 30,386 | 26,451 | 25,969 | 25,711 | 26,019 | 26,371 | 25,046 | 24,693 | 24,506 | 24,190 | 24,028 | 23,732 |
Net Cash (Debt) Net Cash Growth | -20,812 | -22,185 | -23,259 | -23,389 | -21,626 | -22,503 | -23,905 | -19,282 | -23,889 | -20,225 | -19,443 | -14,792 | -16,028 | -16,229 | -17,659 | -15,821 | -18,050 | -18,029 | -19,148 | -18,242 |
Net Cash Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -95.51 | -100.66 | -104.86 | -104.56 | -95.78 | -99.04 | -103.44 | -82.72 | -102.35 | -86.36 | -82.46 | -62.55 | -67.40 | -67.71 | -73.21 | -65.32 | -74.16 | -73.77 | -78.00 | -74.15 |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,913 | 4,332 | 84 | 1,135 | 2,054 | 1,017 | 706 | 2,677 | 447 | 1,978 | -2,971 | 2,613 | 1,950 | 6,469 | -1,518 | 4,924 | 2,452 | 2,541 | 1,672 | 2,504 |
Capital Expenditures CapEx Growth | -287 | -235 | -293 | -360 | -267 | -196 | -322 | -332 | -323 | -279 | -326 | -319 | -350 | -301 | -298 | -305 | -295 | -254 | -340 | -258 |
Free Cash Flow Free Cash Flow Growth | 1,626 | 4,097 | -209 | 775 | 1,787 | 821 | 384 | 2,345 | 124 | 1,699 | -3,297 | 2,294 | 1,600 | 6,168 | -1,816 | 4,619 | 2,157 | 2,287 | 1,332 | 2,246 |
Free Cash Flow Growth | -9.01% | 399.03% | - | -66.95% | 1341.13% | -51.68% | - | 2.22% | -92.25% | -72.45% | - | -50.34% | -25.82% | 169.70% | - | 105.65% | 54.29% | -0.61% | -62.32% | - |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Operating Margin | 4.56% | 5.30% | 1.54% | 3.46% | 5.29% | 6.42% | 2.76% | 5.27% | 6.93% | 7.52% | 5.64% | 4.46% | 6.19% | 6.80% | 3.30% | 5.86% | 6.03% | 6.58% | 5.00% | 6.13% |
Pretax Margin | 3.84% | 4.59% | 0.43% | 2.77% | 4.60% | 5.72% | 1.33% | 3.04% | 6.84% | 6.90% | 2.35% | 3.86% | 5.59% | 6.21% | 2.62% | 5.33% | 5.49% | 6.05% | 3.83% | 5.57% |
Profit Margin | 2.90% | 3.52% | 1.10% | 2.34% | 3.50% | 4.46% | 0.92% | 2.25% | 5.27% | 5.27% | 2.01% | 3.01% | 4.24% | 4.72% | 2.17% | 4.01% | 4.24% | 4.70% | 3.11% | 4.21% |
FCF Margin | 3.22% | 8.16% | -0.42% | 1.53% | 3.59% | 1.68% | 0.84% | 5.19% | 0.28% | 3.99% | -7.73% | 5.35% | 3.66% | 14.63% | -4.55% | 11.56% | 5.58% | 6.00% | 3.64% | 6.27% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.720 | 1.720 | 1.710 | 1.710 | 1.710 | 1.710 | 1.630 | 1.630 | 1.630 | 1.630 | 1.480 | 1.480 | 1.480 | 1.480 | 1.280 | 1.280 | 1.280 | 1.280 | 1.130 | 1.130 |
Dividend Per Share Growth | 0.58% | 0.58% | 4.91% | 4.91% | 4.91% | 4.91% | 10.13% | 10.13% | 10.13% | 10.13% | 15.63% | 15.63% | 15.63% | 15.63% | 13.27% | 13.27% | 13.27% | 13.27% | 18.95% | 18.95% |
Dividend Yield | 1.77% | 2.31% | 1.94% | 2.06% | 1.71% | 1.51% | 1.73% | 1.23% | 1.15% | 1.17% | 1.24% | 1.31% | 1.24% | 1.16% | 0.99% | 1.09% | 1.00% | 0.95% | 0.97% | 1.16% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
PE Ratio | 16.92 | 12.27 | 13.76 | 13.15 | 16.40 | 16.64 | 14.31 | 18.79 | 18.82 | 19.32 | 18.51 | 17.11 | 16.69 | 17.90 | 20.79 | 17.68 | 19.16 | 19.03 | 18.43 | 16.47 |
Forward PE | 14.73 | 11.28 | 13.09 | 10.52 | 10.99 | 12.60 | 11.25 | 13.12 | 14.14 | 13.97 | 13.17 | 12.55 | 13.23 | 14.02 | 16.14 | 14.89 | 16.28 | 17.25 | 16.70 | 13.92 |
P/FCF Ratio | 13.35 | 9.97 | - | 19.32 | 16.47 | 26.80 | 18.80 | 138.44 | 153.58 | 52.54 | - | 12.44 | 9.96 | 9.80 | - | 10.49 | 14.50 | 16.32 | 15.46 | 9.59 |
PS Ratio | 0.42 | 0.32 | 0.39 | 0.37 | 0.46 | 0.54 | 0.48 | 0.69 | 0.73 | 0.70 | 0.65 | 0.61 | 0.64 | 0.68 | 0.78 | 0.71 | 0.78 | 0.82 | 0.81 | 0.68 |